company-logo

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.

TriSalus Life Sciences Dividend Announcement

TriSalus Life Sciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on TriSalus Life Sciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

TriSalus Life Sciences Dividend History

TriSalus Life Sciences Dividend Yield

TriSalus Life Sciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing TriSalus Life Sciences stock? Use our calculator to estimate your expected dividend yield:

TriSalus Life Sciences Financial Ratios

P/E ratio-1.75
PEG ratio0.01
P/B ratio-3.94
ROE284.08%
Payout ratio-0.02%
Current ratio2.33
Quick ratio2.04
Cash Ratio1.37

TriSalus Life Sciences Dividend FAQ

Does TriSalus Life Sciences stock pay dividends?
TriSalus Life Sciences does not currently pay dividends to its shareholders.
Has TriSalus Life Sciences ever paid a dividend?
No, TriSalus Life Sciences has no a history of paying dividends to its shareholders. TriSalus Life Sciences is not known for its dividend payments.
Why doesn't TriSalus Life Sciences pay dividends?
There are several potential reasons why TriSalus Life Sciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will TriSalus Life Sciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While TriSalus Life Sciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is TriSalus Life Sciences a dividend aristocrat?
TriSalus Life Sciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is TriSalus Life Sciences a dividend king?
TriSalus Life Sciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is TriSalus Life Sciences a dividend stock?
No, TriSalus Life Sciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy TriSalus Life Sciences stocks?
To buy TriSalus Life Sciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy TriSalus Life Sciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.